PBYI Financials

Puma Biotechnology Inc - Financial statements & key metrics

Stock Price

$7.47

Market Cap

$368.35M

P/E Ratio

11.9

EPS

$0.61

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$230.47M

Gross Profit

Operating Income

Net Income

$30.28M

EPS (Diluted)

$0.62

Balance Sheet Highlights

Total Assets

$213.33M

Total Liabilities

$121.21M

Shareholders Equity

Cash & Equivalents

$69.22M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$38.92M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

74.5%

Operating Margin

0.2%

Net Margin

0.1%

ROE

0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PBYI revenue?

PBYI's most recent quarterly revenue was $230.47M. Annual revenue can be calculated by summing the four most recent quarters.

Is PBYI profitable?

PBYI reported a profit of $30.28M in the most recent quarter. The net profit margin is 0.1%.

What is PBYI market cap?

PBYI has a market capitalization of $368.35M, making it a small-cap stock.

Does PBYI have debt?

View PBYI's balance sheet for debt information.

What is PBYI cash flow?

Cash flow data is available in the full financial statements.